Patents by Inventor Gürkan Kaya

Gürkan Kaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9993417
    Abstract: The present invention relates to a combination comprising a hyaluronic acid or a salt thereof and a sulphated polysaccharide of which the molecular weight is between 5 and 25 kDa, which is of use in particular for combating the signs of skin ageing or for treating and healing skin wounds.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: June 12, 2018
    Assignee: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Stéphane Poigny, Hélène Hernandez-Pigeon, Jean-Hilaire Saurat, Gürkan Kaya
  • Publication number: 20170049678
    Abstract: The present invention relates to a combination comprising a hyaluronic acid or a salt thereof and a sulphated polysaccharide of which the molecular weight is between 5 and 25 kDa, which is of use in particular for combating the signs of skin ageing or for treating and healing skin wounds.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 23, 2017
    Applicant: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Stéphane POIGNY, Hélène HERNANDEZ-PIGEON, Jean-Hilaire SAURAT, Gürkan KAYA
  • Patent number: 8968751
    Abstract: The inventive compositions for topical application are characterized in that they comprises one or several hyaluronate fragments in the form of a main principle whose molecular weight ranges from 50 000 and 750 000 Da and a retinoid if necessary.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: March 3, 2015
    Assignee: Pierre Fabre Dermo Cosmetique
    Inventors: Jean-Hilaire Saurat, Gürkan Kaya, Pascal Bordat
  • Publication number: 20130059814
    Abstract: Anti-inflammatory dermatological composition for topical administration, characterized in that it comprises 0.005% to 0.1%, preferably 0.01% to 0.05% by weight of a corticosteroid and 0.1% to 1%, preferably 0.5% to 1% by weight of hyaluronate fragments with an average molecular weight of between 20 and 500 kDa, preferably between 20 and 375 kDa, more preferentially between 20 and 150 kDa.
    Type: Application
    Filed: September 4, 2012
    Publication date: March 7, 2013
    Inventors: Christine Chaumont, Jean-Hilaire Saurat, Gürkan Kaya
  • Publication number: 20100197632
    Abstract: Anti-inflammatory dermatological composition for topical administration, characterized in that it comprises 0.005% to 0.1%, preferably 0.01% to 0.05% by weight of a corticosteroid and 0.1% to 1%, preferably 0.5% to 1% by weight of hyaluronate fragments with an average molecular weight of between 20 and 500 kDa, preferably between 20 and 375 kDa, more preferentially between 20 and 150 kDa.
    Type: Application
    Filed: July 10, 2008
    Publication date: August 5, 2010
    Inventors: Christine Chaumont, Jean-Hilaire Saurat, Gürkan Kaya